Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pawlitzki

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
Therapeutic Advances in Neurological Disorders|March 22, 2021
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosisSteffen Pfeuffer, Laura Kerschke, Tobias Ruck, et al.
Annals of Clinical and Translational Neurology|June 19, 2019
CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitisMarc Pawlitzki, Michaela Butryn, Florian Kirchner, et al.
Autoimmunity Reviews|December 4, 2025
Therapeutic approaches in adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of current evidenceJakob Stögbauer, Victoria Schegerer, Clemens Klein, et al.
JAMA Neurology|January 16, 2024
SARS-CoV-2 Vaccination and Neuroimmunological Disease: A ReviewAlice Grizzel Willison, Marc Pawlitzki, Michael Peter Lunn, et al.
European Journal of Neurology|November 24, 2020
Patients with a relapsing course of steroid-responsive encephalopathy associated with autoimmune thyroiditis exhibit persistent intrathecal CD4+ T-cell activationSteffen Pfeuffer, Tobias Ruck, Leoni Rolfes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2024
Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosisTristan Kölsche, Alice Grizzel Willison, Sven G Meuth, et al.
Neurological Research and Practice|August 23, 2023
Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept studyLars Masanneck, Jan Voth, Niklas Huntemann, et al.
Frontiers in Neurology|January 9, 2019
CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome-Sign of InflammationMarc Pawlitzki, Catherine M Sweeney-Reed, Daniel Bittner, et al.
Digital Health|February 10, 2023
Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in GermanyLars Masanneck, Saskia Räuber, Christina B Schroeter, et al.
The Lancet Regional Health. Europe|February 16, 2026
Direct stroke unit access versus a hub-and-spoke model with telemedicine-assisted CT in Germany: a cross-sectional geospatial analysisLars Masanneck, Marius Vach, Julian Caspers, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
Therapeutic Advances in Neurological Disorders|March 22, 2021
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosisSteffen Pfeuffer, Laura Kerschke, Tobias Ruck, et al.
Annals of Clinical and Translational Neurology|June 19, 2019
CSF Neurofilament light chain level predicts axonal damage in cerebral vasculitisMarc Pawlitzki, Michaela Butryn, Florian Kirchner, et al.
Autoimmunity Reviews|December 4, 2025
Therapeutic approaches in adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of current evidenceJakob Stögbauer, Victoria Schegerer, Clemens Klein, et al.
JAMA Neurology|January 16, 2024
SARS-CoV-2 Vaccination and Neuroimmunological Disease: A ReviewAlice Grizzel Willison, Marc Pawlitzki, Michael Peter Lunn, et al.
European Journal of Neurology|November 24, 2020
Patients with a relapsing course of steroid-responsive encephalopathy associated with autoimmune thyroiditis exhibit persistent intrathecal CD4+ T-cell activationSteffen Pfeuffer, Tobias Ruck, Leoni Rolfes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2024
Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosisTristan Kölsche, Alice Grizzel Willison, Sven G Meuth, et al.
Neurological Research and Practice|August 23, 2023
Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept studyLars Masanneck, Jan Voth, Niklas Huntemann, et al.
Frontiers in Neurology|January 9, 2019
CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome-Sign of InflammationMarc Pawlitzki, Catherine M Sweeney-Reed, Daniel Bittner, et al.
Digital Health|February 10, 2023
Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in GermanyLars Masanneck, Saskia Räuber, Christina B Schroeter, et al.
The Lancet Regional Health. Europe|February 16, 2026
Direct stroke unit access versus a hub-and-spoke model with telemedicine-assisted CT in Germany: a cross-sectional geospatial analysisLars Masanneck, Marius Vach, Julian Caspers, et al.
Pageof 14